quinidine has been researched along with Anti-MuSK Myasthenia Gravis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GIULIANI, G | 1 |
| Chandler, JH; Stoffer, SS | 1 |
| Engel, AG; Harper, CM | 2 |
| Brengman, JM; Engel, AG; Fukudome, T; Ohno, K | 1 |
| Sieb, JP | 1 |
| Crielaard, JM; Hansen, I; Wang, FC; Zeevaert, B | 1 |
| Gibson, TC | 1 |
| Gelfand, MC; Knepshield, JH; Lowenthal, DT; Schreiner, GE | 1 |
3 review(s) available for quinidine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
[Diagnosis and therapy of congenital myasthenia syndrome].
Topics: 4-Aminopyridine; Adult; Amifampridine; Central Nervous System Stimulants; Child; Cholinesterase Inhibitors; Edrophonium; Enzyme Inhibitors; Ephedrine; Humans; Infant; Infant, Newborn; Male; Myasthenia Gravis; Potassium Channels; Pyridostigmine Bromide; Quinidine; Syndrome; Thymectomy | 1999 |
The heart in myasthenia gravis.
Topics: Arrhythmias, Cardiac; Cholinesterase Inhibitors; Drug Synergism; Electrocardiography; Heart; Humans; Lidocaine; Meperidine; Methadone; Morphine; Myasthenia Gravis; Myocarditis; Myocardium; Neuromuscular Junction; Phenytoin; Procaine; Quinidine; Vectorcardiography | 1975 |
Dialysis of poisons and drugs--annual review.
Topics: Alcohols; Analgesics; Anti-Bacterial Agents; Antidepressive Agents; Antimetabolites; Barbiturates; Diuresis; Edema; Glutethimide; Halogens; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Immunosuppressive Agents; Metals; Mushroom Poisoning; Myasthenia Gravis; Perfusion; Peritoneal Dialysis; Poisoning; Quinidine; Renal Dialysis; Tranquilizing Agents; Uremia | 1973 |
2 trial(s) available for quinidine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome.
Topics: Action Potentials; Adolescent; Adult; Child; Electric Stimulation; Female; Humans; Male; Median Nerve; Middle Aged; Muscle, Skeletal; Myasthenia Gravis; Prospective Studies; Quinidine; Receptors, Cholinergic; Recombinant Proteins; Syndrome | 1998 |
Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome.
Topics: Adolescent; Adult; Aged; Child; Humans; Middle Aged; Myasthenia Gravis; Point Mutation; Quinidine; Receptors, Cholinergic; Syndrome | 1998 |
4 other study(ies) available for quinidine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
[TREATMENT OF MYASTHENIA].
Topics: Adrenocorticotropic Hormone; Cyclopropanes; Epinephrine; Galantamine; Humans; Hypnotics and Sedatives; Isoflurophate; Morphine; Myasthenia Gravis; Neostigmine; Neuromuscular Nondepolarizing Agents; Nitrogen; Organophosphate Poisoning; Parasympathomimetics; Phosphorus; Poisons; Quinidine; Quinine; Surgical Procedures, Operative; Thymus Gland | 1964 |
Quinidine-induced exacerbation of myasthenia gravis in patient with Graves' disease.
Topics: Aged; Atrial Fibrillation; Graves Disease; Humans; Male; Myasthenia Gravis; Quinidine | 1980 |
AChR channel blockade by quinidine sulfate reduces channel open duration in the slow-channel congenital myasthenic syndrome.
Topics: Cell Line; Cholinergic Antagonists; Humans; Ion Channel Gating; Myasthenia Gravis; Point Mutation; Quinidine; Receptors, Cholinergic; Recombinant Proteins; Syndrome; Transfection | 1998 |
[Slow channel syndrome due to an autosomal translocation at 2q31-9p27].
Topics: Action Potentials; Adult; Autoimmune Diseases; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 9; Diagnosis, Differential; Electromyography; Genetic Heterogeneity; Humans; In Situ Hybridization, Fluorescence; Ion Transport; Male; Muscarinic Antagonists; Myasthenia Gravis; Myasthenic Syndromes, Congenital; Neostigmine; Neural Conduction; Protein Subunits; Quinidine; Receptors, Muscarinic; Translocation, Genetic | 2002 |